RePORT International Resources

APRC 2026, organized by The Union, the Anti-Tuberculosis Association of Thailand under Royal Patronage (ATAT), and the Thoracic Society of Thailand under Royal Patronage, will be held from February 4–7, 2026, in Bangkok, Thailand. With the theme “Transforming Lung Health and Creating a Future Free of Tuberculosis through Research, Innovation, and Networking,” the conference will bring together world-renowned speakers and experts to share insights and lead discussions on: Tuberculosis research and treatment innovations, Emerging respiratory infectious diseases, Universal health coverage and access to care, Environmental and societal impacts on lung health and Breakthroughs in non-communicable respiratory diseases, including asthma, COPD, lung cancer, and interstitial lung disease. Please refer to the website for important dates on abstract submission and registration.

The Workshop will be held as a hybrid meeting from 4-5 December 2025, in San Francisco, US. The deadline for abstract submission is 5 September 2025.

Webinar #1. Inclusion and Accessibility in the Lab Environment (IDEAS): This webinar will focus on becoming a researcher in academic medicine and hearing from researchers with disabilities on how they have navigated and experienced graduate education, training, and beyond, and from faculty on navigating and self-advocating through challenges in both the classroom and lab. Topics will include applying for graduate school and postdoctoral positions, selecting faculty advisors and mentors, unique challenges in the classroom and lab environment, and sources of institutional and community support. Webinar #2. Using Inclusive Language in Scholarly Writing: A Roundtable Discussion: This webinar provided information and guidance on the use of language that is inclusive and accurate in its depiction of identity, lived experiences, health and well-being, and health outcomes. Panelists discussed the principles of using inclusive language across their roles as scholars, authors, reviewers, and editors and offered practical strategies for writing that aligns with inclusive language best practices and welcomes the diversity of all people and their identities. AAMC account access is required.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. Consult Part 2. Section III.1 Eligible Organizations for more information. Please refer to the website for detail announcement and key dates.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. Consult Part 2. Section III.1 Eligible Organizations for more information.   Please refer to the website for detail announcement and key dates.

NOTE: 2025 application cycle is closed. Check the website again for 2026 updates. This track will aim to strengthen prevention, preparedness and response capacities in the face of future health crises, focusing on the priority emerging infectious diseases identified in the 2024 call: respiratory viruses, viral haemorrhagic fevers and arboviruses. The expected projects should adopt an interdisciplinary approach and contribute to advancing research in the service of public health. This call for proposals targets the three founding strands of the PEPR MIE: Section 1: Accelerating the acquisition of fundamental knowledge on emerging infectious diseases Section 2: Promoting innovation and developing new treatments, vaccines and other prevention, diagnostic and surveillance tools for emerging infectious diseases Section 3: Enabling public policies and society to cope with epidemic crises

This resource provides a thorough overview of how to do a robust literature review. It includes text and videos from other sources.

The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions. Please refer to the websites for various funding opportunities and key dates for application.

APPLICATION DEADLINE: 1 December, 2025 11:59 p.m. ET The American Lung Association Catalyst Award is a mentored award meant to support outstanding investigators on the path to independence for research into the mechanisms of lung disease and general lung biology. Preference is given to projects that are novel, innovative in design/approach, utilize modern technologies, and incorporate a multidisciplinary collaborative training plan. The Catalyst Grant is for $50,000 per year, for up to two years. Grants are subject to annual review; the second year of support is based upon demonstration of satisfactory progress. When applicable, researchers are encouraged to investigate hypothesis‐driven research that will inform evidence‐based clinical practice or policy in communities across the United States. Proposals can include examining the cause and prevention of lung diseases like tuberculosis, asthma, COPD, and lung cancer, as well as management of lung disease.

Deadline to submit LOI is September 18, 2025.Refer to the website for other key dates. The Emerging Respiratory Pathogen Award was created to gain a better understanding of the pathobiology and the long term and immediate implications of respiratory infections. This includes emerging problems in known organisms and new and emerging pathogens. The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions: • A new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention • Understanding host factors that alter response to these infections • Understanding individual, regional, or social factors increasing or decreasing community spread of respiratory viruses • Case tracking and epidemiological approaches to understanding emerging respiratory viruses • The pathophysiology of the long term sequalae of respiratory viral infections, including COVID-19 • Key takeaways and lessons learned from the COVID-19 pandemic

The Pediatric Assembly of the American Thoaracic Society (ATS) sponsored this webinar as part of its Virtual International Pediatric Pulmonary Network clinical case series. The first case was presented and discussed by Tony Onyia, MD, University of Nigeria Teaching Hospital, Dept of Pediatrics, Ituku-Ozalla Enugu Nigeria. The second case was presented by Birce Sunman, MD, Gülhane Training and Research Hospital, Ankara and discussed by Prof Hasan Yüksel, Celal Bayar University, School of Medicine, Dept of Pediatric Pulmology, Manisa and Assoc. Prof. Zafer Dökümcü, Ege University, School of Medicine, Dept of Pediatric Surgery, Izmir, Türkiye. The session is chaired by Prof. Joy Eze, University of Nigeria Teaching Hospital, Dept. Of Pediatrics, Ituku-Ozalla Enugu Nigeria and Prof. Özge Yılmaz from Manisa Celal Bayar University, School of Medicine, Dept. Of Pediatric Allergy, Manisa, Türkiye.

ATS recorded video (1 hour 15 min) - Equity in Global Health Research Webinar Recording November 9, 2023

European Respiratory Society (ERS) Long-Term Research Fellowships support researchers and clinicians in the early stages of their careers to carry out basic, translational or clinical research projects lasting between 6–24 months. Fellowship recipients conduct projects at research institutions outside of their home country, enabling fellows to access and learn research techniques that are not available at their home institutions. Long-term fellowships are awarded annually based on scientific merit as well as the skills and experience that fellows can bring to the host institution.

A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 22 affiliated international sites across 18 countries. UCGHI manages and supports the GloCal Health Fellowship.

The conference will take place from 13–17 July 2025 in Kigali, Rwanda. Late-breaker and mpox abstract submissions are now open and will close on 29 April.

The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.

The Union-North America Region (NAR) is the regional arm of the International Union against Tuberculosis and Lung Disease (The Union), a global public health organization with the vision to provide health solutions to the poor. BC Lung is an organizational member of The Union and acts as the Secretariat, organizing and hosting The Union-NAR's annual conference in consultation with the Executive Committee. Date and Location: February 25 – 28, 2026 | Philadelphia, PA, USA Deadline for abstract submission: September 30, 2025.

The call for conference projects and publications covers all the thematic fields of the agency: - All research on HIV/AIDS, sexually transmitted infections (STIs), viral hepatitis, tuberculosis, including research on their co-infections; - Research on emerging and re-emerging infectious diseases, including arboviruses, respiratory viruses and viral hemorrhagic fevers. It is now possible to submit an application for funding continuously throughout the year, according to the following forecast schedule: January 15 – April 30 May 1 – August 31 September 1 – December 15

The ANRS Emerging Infectious Diseases, an autonomous agency of Inserm, supports research to provide scientific responses to infectious diseases in times of crisis and over the long term. It animates, coordinates, evaluates and finances research on HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases such as Covid-19, viral hemorrhagic fevers or arboviruses. It covers all areas of research: basic, translational and clinical research, research in public health and human and social sciences. The agency is developing a global health approach according to the One Health approach, which focuses on the links between human health, animal health and the environment. It thus strengthens France's response in the event of a crisis. The agency is part of an international effort to fight epidemics, in particular in close coordination with Europe and with a network of partners in low- and middle-income countries.